Brittany Maynard was 29 years old and recently married when she was diagnosed with brain cancer in January 2014. By that spring, the tumor had been identified as a grade 4 glioblastoma, and doctors told her she likely had about six months to live. Maynard didn’t want to wait to see how it ended. She researched her options, moved from California to Oregon to access that state’s Death with Dignity Act, and on November 1, 2014, she took a lethal dose of medication prescribed by her physician and died in her bedroom, surrounded by family.
Her story galvanized a global conversation about assisted dying that continues to accelerate. In the decade since her death, several U.S. states have passed similar laws, the United Kingdom has fiercely debated landmark legislation, and countries from Australia to New Zealand have implemented frameworks that would have been politically unthinkable a generation ago. Yet for all the public debate, the operational mechanics of these laws — who qualifies, what the process actually looks like, and how medical professionals navigate the profound ethical terrain — remain poorly understood.
The reality is neither the slippery slope critics fear nor the seamless compassionate release that advocates promise. It is, instead, a complex, highly bureaucratized, deeply human process that different societies have resolved in strikingly different ways.
The Fundamental Distinction: Assisted Suicide vs. Euthanasia
Before examining specific laws, a critical distinction: not all assisted dying is the same. Physician-assisted suicide (now more commonly called medical aid in dying, or MAID, in North America) involves a doctor prescribing a lethal medication that the patient self-administers. Euthanasia involves the physician directly administering the life-ending substance. These are legally and ethically distinct, and different jurisdictions permit one, both, or neither.
Oregon’s Death with Dignity Act, the template for most U.S. state laws, permits only assisted suicide — the patient must be physically capable of taking the medication themselves. This is not a minor procedural detail; it is a foundational safeguard designed to ensure the patient exercises ultimate agency. In contrast, the Netherlands, Belgium, and Canada permit both forms, recognizing that some patients who meet all other criteria are physically unable to self-administer.
The language matters too, and advocates have fought hard to shift it. The term “physician-assisted suicide” carries clinical and moral baggage — “suicide” implies a pathological act, critics argue, whereas someone dying of a terminal illness who seeks control over their final hours is engaged in something categorically different. “Medical aid in dying” has become the preferred term in North America, while “voluntary assisted dying” (VAD) is the term of art in Australia. The vocabulary debate reflects deeper philosophical disagreements about whether death-hastening can ever be a legitimate medical act.
How U.S. State Laws Function: The Oregon Model
Oregon legalized assisted dying in 1997 after voters approved the Death with Dignity Act in two consecutive referendums. The law has since served as the legislative blueprint for most of the other twelve U.S. states plus Washington D.C. where medical aid in dying is now legal, including Washington State, Vermont, California, Colorado, Hawaii, New Jersey, Maine, New Mexico, Delaware, New York, and Illinois; in Montana it exists through court ruling rather than statute.
The eligibility criteria are deliberately stringent. A patient must be at least 18 years old (Oregon dropped its residency requirement in 2023), diagnosed with a terminal illness expected to cause death within six months, mentally competent, and capable of self-administering the medication. They must make two verbal requests to a physician at least fifteen days apart, submit one written request witnessed by two people, and receive confirmation of the diagnosis and prognosis from a second physician. If either physician believes the patient may have a mental disorder affecting their judgment — depression being the most common concern — they must refer the patient to a mental health professional.
Once all criteria are met and the prescription is written, the most commonly prescribed medication is DDMA (digoxin, diazepam, morphine, and amitriptyline), though formulations have evolved over the years to improve reliability and reduce the risk of a prolonged death. Patients typically take the medication at home, often in the presence of family and sometimes a hospice worker. They usually lose consciousness within minutes and die within hours.
The Oregon Health Authority publishes annual reports tracking utilization. In 2022, 278 people died under the act — a number that has grown steadily from the 16 who used it in 1998 but still represents a tiny fraction of Oregon’s roughly 40,000 annual deaths. The typical user is over 65, white, college-educated, enrolled in hospice, and dying of cancer. Critically, studies have found that many patients who obtain the prescription never use it — the mere existence of the option provides psychological comfort, a sense of control, that some patients find sufficient. In 2022, of the 432 prescriptions written, only about 64 percent resulted in reported deaths under the act.
The European Model: Broader Criteria, More Direct Involvement
The Netherlands and Belgium represent the most expansive assisted dying regimes in the world, and examining them reveals how differently societies can approach the same fundamental question.
The Netherlands legalized euthanasia and physician-assisted suicide in 2002 under the Termination of Life on Request and Assisted Suicide Act. The law established six core due care criteria: the patient must have made a voluntary and well-considered request; must be experiencing unbearable suffering with no prospect of improvement; must understand their condition and prognosis; there must be no reasonable treatment alternative; a second independent physician must be consulted; and the procedure must be carried out with medical care. Crucially, the Dutch law does not require terminal illness — it requires unbearable suffering, a concept that has been interpreted expansively over time.
This distinction has enormous practical implications. In the Netherlands, people with severe psychiatric disorders, dementia (under carefully circumscribed circumstances), and even elderly patients who are simply “tired of life” have successfully requested euthanasia. In 2022, the Netherlands recorded 8,720 euthanasia deaths, representing 5.1 percent of all deaths in the country. Of these, 115 involved patients with psychiatric disorders as the primary diagnosis, and 288 involved dementia. These cases generate significant controversy even among supporters of assisted dying who consider terminal illness an essential safeguard.
Belgium, which passed its law the same year as the Netherlands, has followed a broadly similar trajectory. In 2014, Belgium became the first country to remove the age minimum for euthanasia, permitting it for minors with terminal illness who meet strict criteria — a decision that remains among the most debated in end-of-life law globally. In 2022, Belgium recorded 2,966 euthanasia deaths.
Both countries use review bodies composed of doctors, lawyers, and ethicists (Regional Euthanasia Review Committees in the Netherlands, a single federal commission in Belgium) to review every reported case after the fact. The committees assess whether due care criteria were met and can refer cases to prosecutors. In practice, very few cases have been prosecuted. Critics argue this after-the-fact review provides insufficient protection; supporters contend that the careful documentation and dual-physician requirement achieves more rigor than most medical decisions.
Canada’s MAID System: Rapid Evolution and Growing Controversy
Canada’s experience represents perhaps the most dramatic case study in how assisted dying law can transform — and how contentious that transformation becomes. The Supreme Court of Canada struck down the criminal prohibition on assisted suicide in Carter v. Canada in 2015, and Parliament passed Bill C-14 creating a federal MAID framework in 2016.
The original law was restrictive: patients needed a “grievous and irremediable medical condition,” natural death had to be “reasonably foreseeable,” and they needed to be adults capable of consent. But Canada has progressively expanded its criteria. Bill C-7, passed in 2021, removed the “reasonably foreseeable death” requirement and created two tracks: Track 1 for patients whose natural death is reasonably foreseeable and Track 2 for those whose death is not, with additional safeguards for the latter.
The figures that followed alarmed many. In 2022, Canada recorded 13,241 MAID deaths — 4.1 percent of all deaths in the country. That was a 31.2 percent increase from the previous year. The rapid growth has drawn both domestic and international scrutiny, particularly after reports emerged of veterans being offered MAID by a Veterans Affairs Canada caseworker without having asked, disability advocates arguing the system pressures vulnerable people who lack adequate housing and support, and a parliamentary committee debating whether to extend MAID to people with mental illness as their sole underlying condition (a controversial expansion that has been repeatedly delayed amid intense disagreement).
Critics of the expansions, including physicians who have testified before Parliament, argue that the program has moved faster than Canada’s safeguards and social supports, and that it risks offering death as a solution to social problems. Supporters counter that this framing stigmatizes people with disabilities and that autonomy demands that all Canadians with irremediable suffering be treated equally.
The mental illness expansion, originally scheduled for March 2023, has been delayed twice, pushed to March 2027 pending the development of clinical standards and assessor training. The delays reflect a genuine and unresolved expert disagreement about whether psychiatric suffering can ever be reliably judged irremediable.
The Safeguards Debate: Are Current Protections Enough?
Every assisted dying law contains safeguards — waiting periods, multiple physician sign-offs, mental health evaluations, documentation requirements — but whether those safeguards are adequate is the central flashpoint of the policy debate.
The disability rights community has been among the most consistent and forceful critics, and their arguments deserve careful engagement. Organizations like Not Dead Yet argue that in societies where disabled people routinely face inadequate home care, poverty, and social isolation, offering assisted dying without fixing those underlying conditions amounts to coercion by default. When the alternative to death is suffering not from illness but from inadequate social support, the “voluntary” nature of the request becomes compromised.
This concern is not merely theoretical. Researchers studying Oregon’s law have found that patients cite fears of being a burden on family members as a significant motivation — and that concern, critics note, is not purely a medical one. It reflects social and economic pressures that a truly just system would address rather than accommodate.
The medical establishment is also divided. The American Medical Association maintains its opposition to physician-assisted death, arguing it fundamentally conflicts with the physician’s role as healer. “Physician-assisted suicide is fundamentally incompatible with the physician’s role as healer,” the AMA’s position statement reads. The American College of Physicians takes a similar stance. Yet surveys consistently show that individual physicians are more divided, with many supporting at least modest forms of the practice and many who practice in jurisdictions where it is legal participating willingly.
Palliative care specialists occupy a particularly complex position. Many argue that excellent palliative care makes assisted dying unnecessary for the vast majority of patients, and that resources devoted to assisted dying infrastructure should instead go to improving access to hospice and pain management — particularly in under-resourced communities where such access is grossly inadequate. Others in the palliative care community have come to accept assisted dying as a complement to, rather than substitute for, comprehensive end-of-life care.
Where the Law Is Heading: The UK, Australia, and the Next Wave
The United Kingdom shows how fragile that momentum can be. The Terminally Ill Adults (End of Life) Bill, introduced by Labour MP Kim Leadbeater, passed its second reading in the House of Commons in November 2024 by 330 votes to 275 and cleared the Commons in June 2025 by 314 to 291. It would have permitted assisted dying for terminally ill adults in England and Wales with a life expectancy of six months or less, subject to sign-off from two doctors and further independent review. But the bill stalled in the House of Lords and fell when the parliamentary session ended in April 2026, and when it was reintroduced, MPs rejected it at second reading on September 11, 2026, by 286 votes to 270.
The bill generated fierce debate. Former Archbishop of Canterbury Rowan Williams and other religious leaders opposed it; disability rights advocates raised concerns similar to those in Canada; and some palliative care physicians argue the six-month prognosis requirement is inherently unreliable, as doctors frequently misjudge timelines. Supporters point to public polling consistently showing 70-80 percent support for assisted dying in principle in the UK.
Australia offers an instructive model, having implemented state-by-state VAD legislation beginning with Victoria in 2019 and followed by every other state by the end of 2023; the Australian Capital Territory’s scheme began in November 2025, and the Northern Territory passed its law in August 2026. The Australian laws are among the most strictly drafted in the world, requiring multiple assessments, mandatory training for participating practitioners, and a government-administered pharmacy that dispenses the medication — lessons learned partly by studying the challenges and controversies of earlier frameworks elsewhere.
A Death of One’s Own: The Unresolved Human Question
The mechanics of assisted dying law — the waiting periods, the dual confirmations, the pharmacy protocols — can obscure what is ultimately at stake: a person in extremis asking for control over the manner and timing of their death.
The societies that have implemented these laws have not resolved the deep moral questions. They have decided, through democratic processes and legal structures, that in certain circumstances and with certain protections, the answer to that request should be yes. The societies that have not implemented them have decided, at least for now, that the risks of abuse, the threat to vulnerable populations, or the intrinsic moral weight of the act are sufficient reasons to say no.
What the evidence from nearly three decades of implementation in Oregon, more than two decades in the Netherlands, and the rapidly evolving experiences in Canada and Australia suggests is that this is not a decision that, once made, remains static. The criteria expand. The numbers grow. The categories of eligible patients broaden as courts and legislatures respond to new claims of equal treatment. Whether that trajectory represents a reasoned response to genuine need or a gradual erosion of essential protections is the question that will define end-of-life policy for the next generation.
What is clear is that the demand for more control over the circumstances of death is not diminishing. As populations age, as terminal diagnoses become more common, and as citizens in liberal democracies become increasingly accustomed to asserting individual rights in domains once left to fate or medicine, the pressure on lawmakers will only intensify. The question is not whether more countries will join the list — the arc of legislative history suggests they will. The question is what lessons they will choose to take from those who went first.